Methylation-related mutations in the BRCA1 promoter in peripheral blood cells from cancer-free women

International Journal of Oncology

Volumn 39, Issue 1, 2011, Pages 129-135

  Al Moghrabi, Nisreen ^a   Al Qasem, Abeer J S ^a   Aboussekhra, Abdelilah ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

Blood cells; Breast cancer; Breast cancer type 1 susceptibility gene; Methylation; Methylation related mutation

Indexed keywords

BISULFITE; BRCA1 PROTEIN; TUMOR MARKER;

ADULT; ARTICLE; BLOOD CELL; BLOOD SAMPLING; BREAST CANCER; CANCER INVASION; CANCER TISSUE; CLINICAL ARTICLE; CPG ISLAND; EPIGENETICS; FEMALE; GENE MUTATION; GENE SEQUENCE; GENETIC SUSCEPTIBILITY; HUMAN; METHYLATION; ONCOGENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION;

ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; BASE SEQUENCE; BLOOD CELLS; BRCA1 PROTEIN; BREAST NEOPLASMS; CPG ISLANDS; CYTOSINE; DNA METHYLATION; EPIGENOMICS; FEMALE; GENE ORDER; HUMANS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; PROMOTER REGIONS, GENETIC; YOUNG ADULT;

EID: 79956017227     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2011.1021     Document Type: Article

References (36)

1. Bird AP: CpG-rich islands and the function of DNA methylation. Nature 321: 209-213, 1986.
2. Larsen F, Gundersen G and Prydz H: Choice of enzymes for mapping based on CpG islands in the human genome. Genet Anal Tech Appl 9: 80-85, 1992.
3. Jones PA and Baylin SB: The fundamental role of epigenetic events in cancer. Nat Rev Genet 3: 415-428, 2002. (Pubitemid 34587077)
4. Kouidou S, Agidou T, Kyrkou A, et al: Non-CpG cytosine methylation of p53 exon 5 in non-small cell lung carcinoma. Lung cancer 50: 299-307, 2005.
5. Miki Y, Swensen J, Shattuck-Eidens D, et al: A strong candidate for the breast and ovarian cancer susceptibility gene BRCAl. Science 266: 66-71, 1994.
6. Arver B, Du Q, Chen J, Luo L and Lindblom A: Hereditary breast cancer: a review. Semin Cancer Biol 10: 271-288, 2000.
7. Futreal PA, Liu Q, Shattuck-Eidens D, et al: BRCA1 mutations in primary breast and ovarian carcinomas. Science 266: 120-122, 1994. (Pubitemid 24345332)
8. Lancaster JM, Wooster R, Mangion J, et al: BRCA2 mutations in primary breast and ovarian cancers. Nat Genet 13: 238-240, 1996. (Pubitemid 26000445)
9. Thompson ME, Jensen RA, Obermiller PS, Page DL and Holt JT: Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nat Genet 9: 444-450, 1995.
10. Birgisdottir V, Stefansson OA, Bodvarsdottir SK, Hilmarsdottir H, Jonasson JG and Eyfjord JE: Epigenetic silencing and deletion of the BRCA1 gene in sporadic breast cancer. Breast Cancer Res 8: R38, 2006.
11. Butcher DT and Rodenhiser DI: Epigenetic inactivation of BRCA1 is associated with aberrant expression of CTCF and DNA methyltransferase (DNMT3B) in some sporadic breast tumours. Eur J Cancer 43: 210-219, 2007. (Pubitemid 46070215)
12. Hedenfalk I, Duggan D, Chen Y, et al: Gene-expression profiles in hereditary breast cancer. N Engl J Med 344: 539-548, 2001. (Pubitemid 32167867)
13. Van 't Veer LJ, Dai H, van de Vijver MJ, et al: Gene expression profiling predicts clinical outcome of breast cancer. Nature 415: 530-536, 2002.
14. Snell C, Krypuy M, Wong EM, Loughrey MB and Dobrovic A: BRCA1 promoter methylation in peripheral blood DNA of mutation negative familial breast cancer patients with a BRCA1 tumour phenotype. Breast Cancer Res 10: R12, 2008.
15. Xu CF, Brown MA, Nicolai H, Chambers JA, Griffiths BL and Solomon E: Isolation and characterisation of the NBR2 gene which lies head to head with the human BRCA1 gene. Hum Mol Genet 6: 1057-1062, 1997.
16. Xu CF, Chambers JA and Solomon E: Complex regulation of the BRCA1 gene. Journal Biol Chem 272: 20994-20997, 1997.
17. Rice JC, Massey-Brown KS and Futscher BW: Aberrant methylation of the BRCA1 CpG island promoter is associated with decreased BRCA1 mRNA in sporadic breast cancer cells. Oncogene 17: 1807-1812, 1998.
18. Dobrovic A and Simpfendorfer D: Methylation of the BRCA1 gene in sporadic breast cancer. Cancer Res 57: 3347-3350, 1997. (Pubitemid 27355472)
19. Mancini DN, Rodenhiser DI, Ainsworth PJ, et al: CpG methylation within the 5′ regulatory region of the BRCA1 gene is tumor specific and includes a putative CREB binding site. Oncogene 16: 1161-1169, 1998. (Pubitemid 28127515)
20. Catteau A, Harris WH, Xu CF and Solomon E: Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: correlation with disease characteristics. Oncogene 18: 1957-1965, 1999.
21. Bianco T, Chenevix-Trench G, Walsh DC, Cooper JE and Dobrovic A: Tumour-specific distribution of BRCA1 promoter region methylation supports a pathogenetic role in breast and ovarian cancer. Carcinogenesis 21: 147-151, 2000. (Pubitemid 30098695)
22. Elkum N, Dermime S, Ajarim D, et al: Being 40 or younger is an independent risk factor for relapse in operable breast cancer patients: the Saudi Arabia experience. BMC cancer 7: 222, 2007.
23. El-Harith el-HA, Abdel-Hadi MS, Steinmann D and Dork T: BRCA1 and BRCA2 mutations in breast cancer patients from Saudi Arabia. Saudi Med J 23: 700-704, 2002.
24. Matros E, Wang ZC, Lodeiro G, Miron A, Iglehart JD and Richardson AL: BRCA1 promoter methylation in sporadic breast tumors: relationship to gene expression profiles. Breast Cancer Res Treat 91: 179-186, 2005. (Pubitemid 40684930)
25. Wei M, Grushko TA, Dignam J, et al: BRCA1 promoter methylation in sporadic breast cancer is associated with reduced BRCA1 copy number and chromosome 17 aneusomy. Cancer Res 65: 10692-10699, 2005. (Pubitemid 41713336)
26. Esteller M, Fraga MF, Guo M, et al: DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis. Hum Mol Genet 10: 3001-3007, 2001. (Pubitemid 34083486)
27. Catteau A and Morris JR: BRCA1 methylation: a significant role in tumour development? Semin Cancer Biol 12: 359-371, 2002.
28. Esteller M: Epigenetic lesions causing genetic lesions in human cancer: promoter hypermethylation of DNA repair genes. Eur J Cancer 36: 2294-2300, 2000.
29. Esteller M, Silva JM, Dominguez G, et al: Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. J Natl Cancer Inst 92: 564-569, 2000. (Pubitemid 30212318)
30. Hitchins MP, Wong JJ, Suthers G, et al: Inheritance of a cancer-associated MLH1 germ-line epimutation. N Engl J Med 356: 697-705, 2007.
31. Hitchins M, Williams R, Cheong K, et al: MLH1 germline epimutations as a factor in hereditary nonpolyposis colorectal cancer. Gastroenterology 129: 1392-1399, 2005. (Pubitemid 41597381)
32. Gazzoli I, Loda M, Garber J, Syngal S and Kolodner RD: A hereditary nonpolyposis colorectal carcinoma case associated with hypermethylation of the MLH1 gene in normal tissue and loss of heterozygosity of the unmethylated allele in the resulting microsatellite instability-high tumor. Cancer Res 62: 3925-3928, 2002. (Pubitemid 34791053)
33. Chan TL, Yuen ST, Kong CK, et al: Heritable germline epimutation of MSH2 in a family with hereditary nonpolyposis colorectal cancer. Nat Genet 38: 1178-1183, 2006. (Pubitemid 44470364)
34. Brooks AR, Harkins RN, Wang P, Qian HS, Liu P and Rubanyi GM: Transcriptional silencing is associated with extensive methylation of the CMV promoter following adenoviral gene delivery to muscle. J Gene Med 6: 395-404, 2004. (Pubitemid 40228056)
35. Fang JY, Mikovits JA, Bagni R, Petrow-Sadowski CL and Ruscetti FW: Infection of lymphoid cells by integration-defective human immunodeficiency virus type 1 increases de novo methylation. J Virol 75: 9753-9761, 2001. (Pubitemid 32900110)
36. Hachana M, Trimeche M, Ziadi S, Amara K and Korbi S: Evidence for a role of the Simian Virus 40 in human breast carcinomas. Breast Cancer Res Treat 113: 43-58, 2009.